Skip to content
Abierto

Special notice

Glucose Accu-Chek Testing Strips

36C25724Q0588

Department of Veterans Affairs, 257-Network Contract Office 17. In-Vitro Diagnostic Substance Manufacturing.

Awarded

Roche Diabetes Care Inc. Indianapolis 46256

Amount not published

Description

As published on SAM.gov.

NOTICE OF INTENT TO SOLE SOURCE Supplies: Glucose Accu-Check Inform II test strips THIS IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS OR PROPOSALS The Department of Veteran Affairs (VA), VISN 17 Network Contracting Office intends to award a sole source contract for the Dallas VA HealthCare System Pathology and Laboratory Department. This proposed contract action is to procure Glucose Accu-Check testing Strips for Dallas VA HealthCare System Pathology and Laboratory Department.

Base Period:

06/01/2024-05/31/2025 Option Year 1:

06/01/2025-05/31/2026 Option Year 2:

06/01/2026-05/31/2027 Option Year 3:

06/01/2027-05/31/2028 Option Year 4:

06/01/2028-05/31/2029 Classification Code:

6550 NAICS: 325413 Government intends to award a BASE + 4 fixed-price option contract to Roche Diabetes Care, Inc, 9115 Hague Rd., Indianapolis, Indiana 46250. This acquisition is conducted under the authority of 41 U.S.C. 1901 Simplified acquisition procedures as implemented in FAR 8.405-6(a)(1)(B), only one responsible source and no other supplies or services will satisfy agency requirements.

The Contracting Officer has determined that the circumstances of the contract action deem that only one source is capable of providing the services required at the level of quality required because the services are unique or highly specialized. A determination not to compete this proposed contract is based on market research and is solely within the discretion of the government.

This Notice of Intent is not a request for competitive quotations; however, interested parties may identify their interest and capability to respond to this requirement. Any interested party that believes they can fulfill this requirement should submit supporting evidence to be reviewed. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements.

This evidence shall include a letter from the Original Equipment Manufacturer (OEM) stating vendor is an authorized distributor per clause 852.212-72(c). Information must be sent to the Contracting Specialist, Teresa Arzola, Teresa.Arzola@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government.

Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No cost to the government will arise as a result of contractor submissions of responses to this announcement or the government use of such information. Interested parties are responsible for adequately marking proprietary or competitively sensitive information contained in their response. No sub-contracting opportunity is anticipated. Interested parties may e-mail Teresa.Arzola@va.gov by May 10, 2024, at 9:00 am CST.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 2, 2024

    Special notice

    Due May 10, 2024 at 10:00 AM EDT. SAM.gov, notice ae12f16297604714b4a8c448cbefd621

  2. July 3, 2024

    Award notice, originally special notice

    Awarded to Roche Diabetes Care Inc. Indianapolis 46256 for $65,292. SAM.gov, notice 3c8c8198d0154b78a92f88a58dd7c1b3

  3. July 3, 2024

    Special notice

    Due May 10, 2024 at 10:00 AM EDT. SAM.gov, notice 4323e8fd0a38425bb9d8c840102f9381

Points of contact